Jump to contentUniversity of Michigan Health System - link
Department of Internal Medicine - link

SCLERODERMA PROGRAM
Division of Rheumatology

Search this site:
 

About Us



Faculty




Research




Friends & Supporters




FOR PATIENTS
Learn About Scleroderma



For Health Care Professionals

Clinical Trials
Papers
Meeting Presentations
Patient Referrals



Related Programs




Related Links




Internal Resources




Internal Medicine Divisions




Scleroderma Home


 
 
Meeting Presentations

Posters

  1. Volkmann ER, Roth M, Elashoff R, Clements PJ, Furst DE, Khanna D, Goldin J, Tashkin D. Safety and Tolerability of Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  2. Gordon JK, Berrocal VJ, Girish G, Zhang M, Hatzis C, Assassi S, Bernstein EJ, Domsic RT, Hant FN, Hinchcliff ME, Schiopu E, Steen VD, Frech TM, Khanna D. Reliability and Validity of the Total Joint Count and Swollen Joint Count in Early Diffuse Systemic Sclerosis. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  3. Khanna D, Albera C, Fischer A, Seibold JR, Khalidi NA, Raghu G, Chung L, Schiopu E, Chen D, Gorina E. Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  4. Clements PJ, Tashkin D, Roth M, Khanna D, Furst DE, Tseng CH, Volkmann ER, Elashoff R. The Scleroderma Lung Study II (SLS II) Shows That Both Oral Cyclophosphamide (CYC) and Mycophenolate Mofitil (MMF) Are Efficacious in Treating Progressive Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  5. Nagaraja V, Visovatti SH, Gladue H, Berrocal VJ, Serrano J, McLaughlin V, Khanna D. Screening Algorithm for Pulmonary Hypertension in Systemic Sclerosis – Comparison of Predictive Accuracy of Three Algorithms. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  6. Kwakkenbos L, Thombs BD, Bartlett SJ, Carrier ME, Hudson M, Mouthon L, Malcarne VL, Sauvé M, Khanna D. Construct Validity of the Promis-29 in Systemic Sclerosis: Results from the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  7. Martín J, Carmona FD, Fernández-Aranguren T, Serrano-Fernández A, Onat AM, Robledo G, Raya E, Direskeneli H, Sawalha AH, Yavuz S. Evaluation of Systemic Sclerosis Risk Genes in the Turkish Population. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  8. Domsic RT, Khanna D, Lucas M, Steen VD, Furst DE, Lafyatis R, Medsger TA Jr.. The Potential Effect on Recruitment of Restricting Skin Scores Eligibility Criteria in Early Diffuse Scleroderma Trials. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  9. Gordon JK, Berrocal VJ, Assassi S, Bernstein EJ, Domsic RT, Hant FN, Hinchcliff ME, Schiopu E, Steen VD, Frech TM, Khanna D. Inter and Intrarater Reliability of the Modified Rodnan Skin Score in Early Diffuse Systemic Sclerosis. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  10. Khanna D, Allanore Y, Denton CP, Matucci-Cerinic M, Pope JE, Hinzmann B, Briody S, de Oliveira Pena J, Distler O. Patient Perception of Disease Burden in Diffuse Cutaneous Systemic Sclerosis. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  11. Tsou PS, Amin MA, Schiopu E, Fox DA, Khanna D, Sawalha AH. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis Via Repressing Pro-Angiogenic Factors. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  12. Johnson S, Soowamber M, Fransen J, Khanna D, van den Hoogen FHJ, Baron M, Matucci Cerinic M, Denton CP, Medsger TA Jr., Carreira PE, Riemekasten G, Distler JH, Gabrielli A, Steen VD, Chung L, Silver R, Varga J, Müller-Ladner U, Vonk MC, Walker UA, Wollheim F, Herrick AL, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray C, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech TM, Assassi S, Saketkoo LA, Pope JE. There Is a Need for New Systemic Sclerosis Subset Criteria: A Content Analytic Approach. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  13. McCoy SS, Reed TJ, Tsou PS, Khanna D, Kahlenberg JM, Berthier CC. Scleroderma Keratinocytes Promote Fibroblast Activation Independent of TGF-ß. Abstract, 2015 ACR Annual Meeting, San Francisco, CA. Poster presentation.

  14. Pope JE, Khanna D, Fransen J, Johnson SR, Tyndall AG, Matucci-Cerinic M, Naden RP, van den Hoogen FHJ and ACR/EULAR Classification Criteria for Systemic Sclerosis. Classification Criteria for Systemic Sclerosis: Preliminary Results. Abstract, 2012 ACR Annual Meeting, Late Breaking Abstracts Poster Session.

  15. Khanna D, Seibold J, Merkel P, Mayes MD, Phillips K, Simms RW, Assassi S, Clements PJ, Furst DE. Construct Validity of the Saint George’s Respiratory Questionnaire in An Observational Cohort of Patients with Early Diffuse Systemic Sclerosis. Abstract, ACR 2011 Meeting Chicago, IL. Poster Presentation.

  16. Khanna D, Forsythe A, Khanna P. Patient Management/Treatment and Outcomes of Gout Between Primary Care Physicians and Rheumatologists: A Chart Review of 1,039 Patients with Gout In the United States. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  17. Khanna D, Poiraudeau S, Gelhorn H, Hunsche E, Papadakis K, Perchenet L, Mattera MS, Vernon M, Mouthon L. Development and Content Validity of the Hand Disability in Systemic Sclerosis—Digital Ulcers (HDISS-DU) Scale. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  18. Khanna P, Tausche AK, Forsythe A, Goren A, Khanna D. Gout Patient Burden Associated with Flares, Tophi, and Awareness of Uric Acid Levels in US and EU. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  19. Khanna P, Beaton CA, Persselin JE, Hays RD, Furst DE, Paulus HE, Terkeltaub R, Maranian P,  Khanna D. Impact of Acute Gout Flares on Health Related Quality of Life (HRQOL) and Productivity in Patients with Chronic Gout. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  20. Bae S, Allanore Y, Furst DE, Bodukam V, Coustet B, Morgaceva O, Paul Maranian P,  Khanna D. Associations Between the UCLA SCTC GIT 2.0 Vs. Objective Tests of Upper Gastrointestinal Involvement in Systemic Sclerosis. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  21. Khanna P, Hirsch J, Lee SJ, Terkeltaub R, Singh J, Kavanaugh AF, Sarkin A, Khanna D. Gout Characteristics, Health-Related Quality of Life and Health Care Utilization: Caucasians Vs. Non-Caucasians In An Observational Cohort of Patients with Gout. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  22. Khanna P, Singh MK, FitzGerald JD, Bae S, Prakash S, Kaldas M, Gogia M, Maranian P, Terkeltaub R, Khanna D. Pharmacological Treatment of Acute Gout: A Systematic Review. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  23. Khanna P, Singh MK, Bae S, FitzGerald JD, Prakash S, Kaldas M, Gogia M, Maranian P, Terkeltaub R, Khanna D. Oral Urate Lowering Therapies in Chronic Gout: A Systematic Review and Meta-Analysis. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  24. Johnson SR, Fransen J, Khanna D, Medsger TA, Peschken CA, Carreira P, Riemekasten G, Tyndall AG,  Matucci-Cerinic M, Baron M, Van den Hoogen F, Pope JE. Validation of Potential Classification Criteria for Systemic Sclerosis. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  25. Au KM, Khanna D, Divekar AA, Singh RR, Kaplan MJ,  McMahon MA, Furst DE, Ragavendra N, Maranian P, Zhao W. Atherosclerosis Biomarkers in Systemic Sclerosis- A Multiplex Analysis. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  26. Kushi J, Csuka ME, Hummers LK, Wigley FM, Hsu VM, Khanna D, Molitor JA, Steen VD. Elevated Pulmonary Vascular Resistance At Rest Is Associated with Exercise Pulmonary Arterial Hypertension in Systemic Sclerosis Patients without Pulmonary Hypertension Hemodynamics At Rest. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  27. Ghrenassia E, Avouac J, Derk CT, Airo P, Khanna D, Berezne A, Tiev K, Ingegnoli F,Rosato E, Caramaschi P, Hesselstrand R, Riccieri V, Bae S, Steen VD, Allanore Y. Watermelon Stomach in Systemic Sclerosis: A EUSTAR Case-Control Study. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  28. Saketkoo LA, Huscher D, Khanna D, Dellaripa PF, Flaherty K, Matteson EL, Oddis CV, Phillips K, Wells AU, Denton CP, Distler O, Kowal-Bielecka OM, Pittrow D, Christmann R, Sandorfi N, Strand V,Brown KK  Seibold JR. Developing a Disease Activity and Therapeutic Response Index in Connective Tissue Disease Related Interstitial Lung Disease: Initial Results of a Delphi Exercise. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  29. Gordon JK, Doobay K,  Horn E,  Bolster MB, Shapiro LS,  Khanna D, Frech TM, Fields K, Derk CT, Hummers LK, Mayes MD, Steen VD. Clinical and Hemodynamic Features of Scleroderma Patients with Pulmonary Venous Hypertension Versus Pulmonary Arterial Hypertension. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  30. Sharif R, Mayes MD, Tan FK, Gorlova O,  Hummers LK, Shah AA, Furst DE, Khanna D, Martin J, Bossini-Castillo L, Gonzalez EB, Draeger HT, Ying J,  Agarwal SK, Arnett FC, Wigley FM, Assassi S. A Functional IRF5 Variant Predicts Prognosis in Patients with Systemic Sclerosis. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  31. Seibold JR,  Wigley FM, Schiopu E, Denton CD, Silver RM, Steen VD, Medsger TA, Mayes MD,  Chatterjee S, Chung L,  Csuka ME, Khanna D, Frech TM,  Molitor JA, Rothfield NF, Herrick AL,  Simms RW, Pope JE, Rollins KD, Arneson C, Wade M. Digital Ischemic Ulcers in Scleroderma Treated with Oral Treprostinil Diethanolamine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. Abstract, ACR 2011 Meeting Chicago, IL. Poster presentation.

  32. Wangkaew S, Impens AJ, Rubenfire M, Schiopu E, McLaughlin VV, Montgomery DG, Seibold JR:  Correlation between submaximal exercise testing and right heart catheterization in patients with systemic sclerosis (SSc) (PDF) Abstract, ACR National Meeting, 2009.

  33. Impens AJ, Hinchcliff ME, Hummers LK, Mayes MM, Derk CT, Shapiro LS, Domsic RT, Segal BM, Goldberg AZ, Alkassab F, Steen VD, and the PHAROS Investigators:  Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS):  Utility of six minute walk test (PDF) Abstract, ACR National Meeting, 2009.

  34. Mahmood F, Impens AJ, Schiopu E, Phillips K, Lowe L, Olsen S, Seibold JR: Clinical and histopathologic comparison of generalized subcutaneous morphea (GSM) with eosinophilic fasciitis (EF) (PDF) Abstract, ACR National Meeting, 2009.

  35. Seibold JR, Denton CP, Distler O, Grnig E, McLaughlin V, Müller-Ladner U, Pope J, Vonk M, Coghlan G:  The DETECT study:  A two-stage, prospective, observational, cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary hypertension. (PDF) Abstract, ACR National Meeting, 2008.

  36. Chan KM, Tishkowski E, Impens AJ, Ojo T, McLaughlin VV, Seibold JR.  Doppler echocardiography overestimates pulmonary hypertension in patients with scleroderma interstitial lung disease. (PPT) Abstract, ACR National Meeting, 2008.

  37. Impens AJ, Wangkaew S, Rubenfire M, McLaughlin VV, Montgomery DG, Seibold JR.  Correlations of 6-minute walk distance (6MWD) with subjective measures of dyspnea in systemic sclerosis (SSc) patients. (PDF) Abstract, ACR National Meeting, 2008.

  38. Hou Y, Rabquer BJ, Jaffe ML, Del Galdo F, Jimenez SA, Haines III GK, Seibold JR, Barr WG, Massa MC, Koch AE. Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion. (PDF) Abstract, ACR National Meeting, 2008.

  39. Rabquer BJ, Hou Y, Del Galdo F, Haines III GK, Jaffe ML, Jimenez SA, Seibold JR, Koch AE. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion. (PDF) Abstract, ACR National Meeting, 2008.

  40. Schiopu E, Impens AJ, Phillips K, Denton CP, Furst DE, Guillevin L, Rugin LJ, Wells AU, Matucci-Cerinic M, Riemekasten G, Emery P, Chadha-Boreham H, Charef P, Roux S Black CM, Seibold JR:  Sub-maximal exercise testing in the prospective assessment of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc):  Correlations with objective and subjective measures of parenchymal lung disease. (PDF) Abstract, ACR National Meeting, 2007.

  41. Schiopu E, Hsu VM, Hummers L, Shapiro L, Mayes MD, Csuka ME, Derk C, Chung L, Varga J, Furst DE, Silver RM, Wigley FM, Seibold JR, Steen VD:  Pulmonary hypertension assessment and reaction of outcomes in scleroderma (systemic sclerosis, SSc):  PHAROS. (PDF) Abstract, ACR National Meeting, 2007.

  42. Impens AJ, Schiopu E, Phillips K, Denton CP, Furst DE, Guillevin L, Rubin LJ, Wells AU, Matucci-Cerinic M, Riemekasten G, Emory P, Chada-Boreham H, Charef P, Roux S, Black CM, Seibold JR:  Correlations of objective ratings of respiratory function with traditional measures of parenchymal lung disease in systemic sclerosis (SSc) patients with interstitial lung disease. (PDF) Abstract, ACR National Meeting, 2007.

  43. Impens AJ, Schiopu E, Buch MH, Seibold JR:  Physician and patient assessment of disease severity in systemic sclerosis (SSc). (PDF) Abstract, ACR National Meeting, 2007.

  44. Impens AJ, Guerriere J, Schiopu E, Gendrano N, Seibold JR, Rosen RC:  Sexual activity and functioning in female scleroderma (SSc) patients. (PDF) Abstract, American Psychological Association National Meeting, 2007.

  45. Impens AJ, Chung KC, Buch MH, Schiopu E, Kotsis S, Burns P, Seibod JR:  Comparison of pain scales in systemic sclerosis (SSc) patients. (PDF) Abstract, EULAR, 2007.

  46. Impens AJ, Chung KC, Buch MH, Schiopu E, Kotsis S, Burns P, Seibold JR: Influences of clinical features of systemic sclerosis (SSc) on the Michigan Hand Questionnaire (MHQ). (PDF) Abstract, ACR National Meeting, 2006.

  47. Impens AJ, Chung KC, Buch MH, Schiopu E, Kotsis S, Burns P, Seibold JR: Validation of the Michigan Hand Outcomes Questionnaire (MHQ) in Systemic Sclerosis (SSc). (PDF) Abstract, ACR National Meeting, 2006.

  48. Schiopu E, Hsu VM, Impens AJ, Guerriere-Rothman JA, McCloskey DA, Wilson JE, Seibold JR:  Controlled trial of Tadalafil in Raynaud Phenomenon (RP) secondary to systemic sclerosis (SSc). (PDF) Abstract, ACR National Meeting, 2006.

 

Back to For Health Care Professionals - Top of Page

 
 
   
   

U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright Regents of the University of Michigan
Template developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index